Companies Act

R&D activity of Covid-19 vaccine, drugs & medical devices brought under CSR Policy 

Research and development activity of Covid-19 vaccine, drugs and medical devices brought under CSR Policy of companies

MINISTRY OF CORPORATE AFFAIRS
 
NOTIFICATION
 
New Delhi, the 24th August, 2020
 
G.S.R. 526(E).—In exercise of the powers conferred by section 135 and sub-sections (1) and (2) of section 469 of the Companies Act, 2013 (18 of 2013), the Central Government hereby makes the following rules further to amend the Companies (Corporate Social Responsibility Policy) Rules, 2014, namely:-
 
1. Short title and commencement.—(1) These rules may be called the Companies (Corporate Social Responsibility Policy) Amendment Rules, 2020.
 
(2) They shall come into force on the date of their publication in the Official Gazette.
 
2. In the Companies (Corporate Social Responsibility Policy) Rules, 2014 (hereinafter referred to as the said rules), in rule 2, in sub-rule (1), in clause (e), the following proviso shall be inserted, namely:-
 
“Provided that any company engaged in research and development activity of new vaccine, drugs and medical devices in their normal course of business may undertake research and development activity of new vaccine, drugs and medical devices related to COVID-19 for financial years 2020-21, 2021-22 and 2022-23 subject to the conditions that-
 
(i) such research and development activities shall be carried out in collaboration with any of the institutes or organisations mentioned in item (ix) of Schedule VII to the Act.
 
(ii) details of such activity shall be disclosed separately in the Annual Report on CSR included in the Board’s Report”.
 
3. In the said rules, in rule 4, in sub-rule 1, the words “excluding activities undertaken in pursuance of its normal course of business” shall be omitted.
 
4. In the said rules, in rule 6, in sub-rule (1),—
 
(i) first proviso shall be omitted;
 
(ii) In the second proviso, the word “further” shall be omitted.
 
[E-F.No. CSR-07/2/2020-CSR-MCA]
 
GYANESHWAR KUMAR SINGH, Jt.Secy.
 
Note:The principal rules were published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), videnumber G.S.R. 129(E), dated the 27th February, 2014 and were subsequently amended by notification number G.S.R. 644(E), dated the 12th September, 2014, notification number G.S.R. 43(E), dated the 19th January, 2015, notification number G.S.R. 540 (E), dated the 23rd May, 2016 and notification number G.S.R. 895(E), dated the 19th September, 2018.
 

Download Notification Click Here >>

Share

Recent Posts

  • Income Tax

NSDL latest e-TDS TCS RPU Version 5.8 and FVU 9.03 applicable from January 2026 – Download

NSDL latest e-TDS TCS RPU Version 5.8 from FY 2007-08 NSDL has revised the e-TDS TCS RPU utility for preparing…

3 hours ago
  • Income Tax

Assessee bound to deduct TDS u/s 194I and 194J on the provisions made in accounts

Assessee duty bound to deduct TDS u/s 194I and 194J of the Act on the provisions for rent and professional…

7 hours ago
  • DGFT

A Notification acquires force of law only upon its publication in Official Gazette – SC

Notification issued acquires the force of law only upon its publication in the Official Gazette – Supreme Court In a…

20 hours ago
  • Income Tax

Case remitted to verify claim of RTO liaisoner that cash deposited belonged to vehicle owners

Case remitted to verify claim of RTO liaisoner that the cash deposited in his account was of vehicle owners and…

21 hours ago
  • Empanelment

J&K Bank Ltd. invites on-line applications for empanelment as Stock Auditors

The Jammu & Kashmir Bank Ltd. invites on-line applications for empanelment as Stock Auditors for 3 Financial Years i.e. from…

1 day ago
  • Income Tax

Broken period interest on securities held as stock-in-trade is revenue expenditure

Broken period interest paid on purchase of securities was revenue expenditure since the securities constituted stock-in-trade In a recent judgment,…

1 day ago